Web Based Investigation of Natural History of Keloid Disorder, an Online Survey

NCT01423981 | Recruiting

• 1 other identifier: Tirgan 11-01
• Study Type: observational
• Target: 10,000
• Locations: 1 country
• Sites: 1

Brief Summary

This trial intends to gather very basic clinical information about keloid, its patterns of presentation, family history, ethnic background and correlation with the type of keloid, as well as prior treatment results that patients have had received.

Conditions

Keloid

Keywords

Keloid; Scar; hypertrophic scar; familial keloid

Outcome Measures

Primary Outcomes (1)

• Determine the prevalence different phenotypes of keloid in participants.

  Prevalence of different phenotypes of keloid will be measured in the study population and reported. Prevalence of familial keloid in the study population will also be determined and reported. Data will be analyzed to determine the distribution of keloid among different ethic groups. Data will be analyzed to report the percentage of patients who have had one or more treatments and the percentage of patients who have had successful treatments.

  Two years

Study Arms (1)

Patients with keloid disorder.

All participants have a clinical diagnosis of keloid.

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients with keloid disorder.

You may qualify if:

• Patients must have clinically confirmed diagnosis of keloid
• Adults, age over 18
• Parent or legal guardian may participate if patient is under the age of 18
• Able and willing to complete a web based survey

Sponsors & Collaborators

• Tirgan, Michael H., M.D.: lead

Study Sites (1)

Michael H. Tirgan, MD

New York, New York, 10023, United States

RECRUITING

Related Links

• Official Study Website

MeSH Terms

Conditions

Keloid; Cicatrix; Cicatrix, Hypertrophic

Condition Hierarchy (Ancestors)

Collagen Diseases; Connective Tissue Diseases; Skin and Connective Tissue Diseases; Fibrosis; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Michael H Tirgan, MD

  Keloid Research Foundation

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Michael H Tirgan, MD

CONTACT

(212) 874 4200; htirgan@gmail.com

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: INDIV
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 23, 2011
• First Posted: August 26, 2011
• Study Start: November 1, 2011
• Primary Completion (Estimated): December 1, 2030
• Study Completion (Estimated): June 1, 2031
• Last Updated: October 4, 2016

Record last verified: 2016-10

Data Sharing

• IPD Sharing: Will share

Locations

US (1)